| abstract |
among others, the present disclosure provides compounds that comprise universal antibody binding fractions and targeting fractions. in some embodiments, the compounds provided recruit various types of antibodies to diseased cells, such as cancer cells, and induce immunological activities to kill those cells. the technologies provided are useful for treating various diseases, including cancer. |